Wildcat Capital Management as of Dec. 31, 2024
Portfolio Holdings for Wildcat Capital Management
Wildcat Capital Management holds 8 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Frontier Group Hldgs (ULCC) | 79.0 | $200M | 28M | 7.11 | |
| Rlx Technology Sponsored Ads (RLX) | 15.4 | $39M | 18M | 2.16 | |
| Allogene Therapeutics (ALLO) | 2.5 | $6.2M | 2.9M | 2.13 | |
| Urogen Pharma (URGN) | 2.1 | $5.3M | 496k | 10.65 | |
| Kronos Bio | 0.5 | $1.2M | 1.3M | 0.95 | |
| Gitlab Class A Com (GTLB) | 0.3 | $642k | 11k | 56.35 | |
| Procore Technologies (PCOR) | 0.2 | $607k | 8.1k | 74.93 | |
| Silexion Therapeutics Corp Shs New | 0.1 | $228k | 113k | 2.01 |
